Form 4: HealthStream EVP Plans Sale of Shares Under 10b5-1 Plan

HealthStream's Executive Vice President, Kevin P. O'Hara, plans to sell 2,000 shares of common stock on December 8, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Kevin P. O'Hara, Executive Vice President of HealthStream Inc. (HSTM), reported a planned transaction to dispose of common stock.
• The transaction involves the sale of 2,000 shares of HealthStream common stock.
• The planned sale date is December 8, 2025.
• The shares are expected to be sold at a weighted average price of $24.2601 per share, with individual trades ranging from $24.25 to $24.29.
• Following this planned transaction, O'Hara will beneficially own 16,373 shares of common stock.
• The transaction is being executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan, indicating it was scheduled in advance.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to an insider sale, but mitigated by the fact it's a pre-planned 10b5-1 transaction and represents a moderate portion (~11%) of the insider's holdings, not a full liquidation.

Positives

• The transaction is conducted under a Rule 10b5-1(c) plan, which suggests the sale was pre-scheduled and not based on immediate, non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived by investors as a signal of reduced confidence or a need for liquidity, though the 10b5-1 plan mitigates this interpretation.

Risks

• No specific risks were mentioned in the filing beyond the inherent market risks associated with stock transactions.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or strategic direction, focusing solely on the planned insider stock transaction.

Management Comments

• Kevin P. O'Hara undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Industry Context

This filing is a routine insider transaction report and does not contain information that directly relates to broader industry trends or competitive landscape analysis.

Stakeholder Impact

• Shareholders may interpret the insider sale as a neutral to slightly negative signal, although the 10b5-1 plan suggests it's not based on new, adverse information.

Next Steps

• The reporting person will provide full information regarding the number of shares and prices upon request to the SEC staff, the issuer, or a security holder.

Key Dates

Recommendation

The planned sale by an Executive Vice President, while an insider transaction, is being conducted under a Rule 10b5-1 plan, which typically indicates a pre-scheduled disposition for personal financial planning rather than a reaction to new company-specific information. The amount sold represents approximately 11% of the insider's total holdings, which is not a complete divestment. Therefore, this single transaction is unlikely to significantly alter the fundamental investment thesis for HealthStream, warranting a 'hold' recommendation based solely on this filing.

Keywords

HealthStream, HSTM, Insider Trading, Form 4, Stock Sale, Executive Vice President, 10b5-1 Plan, Beneficial Ownership